The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 26, 2014
Filed:
Jan. 24, 2012
Kazuya Tatani, Nagano, JP;
Atsushi Kondo, Nagano, JP;
Tatsuhiro Kondo, Niigata, JP;
Naohiro Kawamura, Nagano, JP;
Shigeki Seto, Nogi, JP;
Yasushi Kohno, Nogi, JP;
Kazuya Tatani, Nagano, JP;
Atsushi Kondo, Nagano, JP;
Tatsuhiro Kondo, Niigata, JP;
Naohiro Kawamura, Nagano, JP;
Shigeki Seto, Nogi, JP;
Yasushi Kohno, Nogi, JP;
Kissei Pharmaceutical Co., Ltd., Nagano, JP;
Kyorin Pharmaceutical Co., Ltd., Tokyo, JP;
Abstract
The present invention provides a compound represented by the general formula (I) of the present invention, which has EPreceptor antagonism: wherein A represents a benzene ring, a pyridine ring, or the like; Yrepresents a Calkylene group or the like; Yrepresents a single bond or the like; Z represents —C(═O)—NHSOR, an acidic 5-membered hetero ring group, or the like; Rrepresents a hydrogen atom or the like; Rrepresents a phenyl group, a 5-membered aromatic heterocyclic group, or the like; Rrepresents a halogen atom, a Calkoxy group, or the like; Rrepresents a hydrogen atom, a halogen atom, or the like; Rrepresents a hydrogen atom or the like; and Rrepresents a Calkyl group or the like], or a pharmaceutically acceptable salt thereof. Furthermore, the compound (I) of the present invention can be used as an agent for treating or preventing LUTS, in particular, various symptoms of OABs.